Vous n'êtes pas connecté
Intellia Therapeutics highlights recent company progress Intellia Therapeutics reported operational highlights. John Leonard MD, Intellia President and Chief Executive Officer, said: “We are off to an excellent start in 2025 with renewed focus and strong operational execution. We are excited by the clinical data presented during the fourth quarter. Our Phase 1/2 results in [...]
CALGARY, Alberta, March 05, 2025 (GLOBE NEWSWIRE) — South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) reports its fourth-quarter...
Intellia reports better-than-expected fourth-quarter 2024 results. The company provides updates on its pipeline candidates.
STEALTHGAS, a ship-owning company serving the liquefied petroleum gas sector of the international shipping industry, announced today its unaudited...